TJX(TJX)
Search documents
TJX (TJX) Stock Dips While Market Gains: Key Facts
ZACKS· 2025-05-13 22:50
Company Performance - TJX closed at $130.82, reflecting a -0.51% change from the previous day, underperforming the S&P 500's gain of 0.73% [1] - Over the past month, TJX shares gained 0.68%, lagging behind the Retail-Wholesale sector's gain of 9.91% and the S&P 500's gain of 9.07% [1] Upcoming Financial Results - TJX is set to announce its earnings on May 21, 2025, with an expected EPS of $0.90, down 3.23% from the prior-year quarter [2] - The consensus estimate for revenue is $12.97 billion, indicating a 3.94% increase compared to the same quarter of the previous year [2] Annual Estimates - For the annual period, the Zacks Consensus Estimates project earnings of $4.43 per share and revenue of $58.75 billion, reflecting increases of +3.99% and +4.24% respectively from the last year [3] Analyst Estimates - Recent modifications to analyst estimates for TJX reflect shifting short-term business dynamics, with positive revisions indicating analysts' confidence in the company's performance [4] - The Zacks Rank system, which incorporates estimate changes, provides actionable ratings, with TJX currently holding a Zacks Rank of 2 (Buy) [5][6] Valuation Metrics - TJX has a Forward P/E ratio of 29.67, which is higher than the industry average of 22.19, suggesting that TJX is trading at a premium [7] - The company has a PEG ratio of 3.27, compared to the Retail - Discount Stores industry's average PEG ratio of 2.62, indicating a higher valuation relative to expected earnings growth [8] Industry Ranking - The Retail - Discount Stores industry, part of the Retail-Wholesale sector, has a Zacks Industry Rank of 75, placing it in the top 31% of over 250 industries [8]
The TJX Companies, Inc. (TJX) Hit a 52 Week High, Can the Run Continue?
ZACKS· 2025-05-13 14:15
Core Viewpoint - TJX shares have shown strong performance, reaching a new 52-week high and outperforming the broader retail sector and discount stores industry [1][2]. Financial Performance - TJX has consistently exceeded earnings expectations, reporting EPS of $1.23 against a consensus estimate of $1.16 in its last earnings report [2]. - For the current fiscal year, TJX is projected to achieve earnings of $4.43 per share on revenues of $58.75 billion, reflecting a 3.99% increase in EPS and a 4.24% increase in revenues [3]. - The next fiscal year forecasts earnings of $4.86 per share on $61.83 billion in revenues, indicating year-over-year changes of 9.57% and 5.25%, respectively [3]. Valuation Metrics - TJX's current valuation metrics indicate a premium, trading at 29.7X current fiscal year EPS estimates compared to the peer industry average of 22.2X [7]. - On a trailing cash flow basis, TJX trades at 24X versus a peer group average of 16.6X, with a PEG ratio of 3.27, suggesting it is not among the top value stocks [7]. Style Scores and Zacks Rank - TJX has a Value Score of D, a Growth Score of A, and a Momentum Score of D, resulting in a VGM Score of B [6]. - The stock holds a Zacks Rank of 2 (Buy), supported by rising earnings estimates, indicating potential for further gains [8].
Should You Buy TJX Companies Stock Right Now?
The Motley Fool· 2025-05-10 09:30
Core Viewpoint - The article discusses the investment position of Parkev Tatevosian, CFA, and mentions the Motley Fool's involvement with TJX Companies, highlighting their recommendation and potential compensation structure [1] Company Analysis - Parkev Tatevosian has no position in any of the stocks mentioned, indicating a neutral stance on the specific stocks discussed [1] - The Motley Fool has positions in and recommends TJX Companies, suggesting a positive outlook on the company's performance [1] Disclosure and Compensation - The Motley Fool has a disclosure policy that outlines its investment positions and potential conflicts of interest [1] - Parkev Tatevosian may be compensated for promoting the Motley Fool's services, which could influence his opinions, although he asserts that his views remain independent [1]
The TJX Companies' Stock Rises 32% in a Year: To Hold or Fold?
ZACKS· 2025-05-06 18:05
Core Viewpoint - The TJX Companies, Inc. has experienced a significant stock price increase of 31.7% over the past year, prompting discussions on whether to take profits or anticipate further growth [1]. Company Performance - TJX has outperformed the Zacks Retail - Discount Stores industry, the broader Retail and Wholesale sector, and the S&P 500, which recorded gains of 16%, 13.2%, and 9.8% respectively [1]. - The company has also surpassed key competitors such as Burlington Stores, Costco, and Dollar General, with Burlington and Costco achieving gains of 26.3% and 31.6% respectively, while Dollar General saw a decline of 34.1% [4]. Stock Analysis - Closing at $128.94, TJX stock is currently 1.8% below its 52-week high of $131.30, indicating a slight pullback after a strong rally [5]. - The stock continues to trade above its 50 and 200-day moving averages, suggesting a bullish trend [5]. Growth Strategy - TJX's flexible off-price model allows for quick adjustments to trends, offering fresh, branded products at strong value, which keeps customers engaged and encourages repeat visits [8]. - The company has expanded its global presence, adding 131 stores in fiscal 2025, with plans to open approximately 130 net new stores in fiscal 2026, aiming for over 5,200 locations [10]. - The e-commerce strategy has been advanced, with growth in online sales through expanded assortments and an enhanced digital shopping experience [10]. Financial Outlook - For fiscal 2026, TJX projects consolidated sales between $58.1 billion and $58.6 billion, reflecting a 3% to 4% year-over-year increase, with earnings expected to rise from $4.26 to between $4.34 and $4.43 [12]. - Comparable store sales growth is anticipated to be between 2% and 3% for fiscal 2026, indicating continued customer demand [11]. Valuation - TJX is currently trading at a forward 12-month price-to-earnings (P/E) multiple of 28.39X, which is lower than the industry average of 32.41X, suggesting it is an attractive value opportunity [13]. Challenges - The company faces challenges such as rising operating costs due to inflation and wage increases, which may impact margins [16]. - Foreign exchange headwinds are expected to negatively affect profitability, with a projected impact of about 0.2 percentage points on the pretax profit margin and a 3% drag on earnings per share growth for fiscal 2026 [18]. - A slight decline in gross margin is forecasted for fiscal 2026, attributed to unfavorable foreign exchange and inventory hedge [19].
The TJX Companies: Valuation And Tariff Concerns Are Worrying
Seeking Alpha· 2025-05-05 18:38
Company Overview - The TJX Companies, Inc. has a market capitalization of $143.02 billion, positioning it as a significant player in the retail sector, although not the largest [1]. Industry Insights - The focus of Crude Value Insights is on cash flow and companies within the oil and natural gas sector, emphasizing value and growth prospects [1].
Wall Street Analysts See TJX (TJX) as a Buy: Should You Invest?
ZACKS· 2025-05-05 14:35
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about TJX (TJX) .TJX currently has an average brokerage recommendation ...
There's Still Time for Investors to Take Advantage of These 2 Dividend Raises From Top Retail Stocks
The Motley Fool· 2025-05-01 14:53
Group 1: Costco - Costco raised its quarterly dividend by 12% to $1.30 per share, resulting in an annual payout of $5.20 [2] - The company faces challenges due to tariffs impacting one-third of its sales from imported goods, particularly from targeted countries like China, Canada, and Mexico [4][3] - Despite a recent decline in stock value, Costco is actively working to mitigate tariff impacts by pressuring suppliers to reduce prices [5] - The dividend increase will take effect on May 16, with a yield of 0.5% at the current share price [7] Group 2: TJX Companies - TJX announced a 13% increase in its dividend to $0.425 per share, marking its 28th dividend hike in the past 29 years [8] - The company plans to spend $2 billion to $2.5 billion on share buybacks in the current fiscal year, supporting its stock price [9] - TJX's profitability allows it to manage both dividend increases and stock repurchases, driven by effective inventory management and flexible buying strategies [10] - The company experienced growth in fiscal 2025 through new store openings and a 4% rise in same-store sales [10] - The new dividend will be distributed on June 5, yielding 1.3% at the latest closing price [12]
Jim Cramer's top stock picks amid trade war
Finbold· 2025-04-28 14:14
Summary:⚈Jim Cramer sees TJX Companies as the top retail winner of the trade war.⚈ He believes U.S. retailers like Macy’s and Kohl’s could benefit from tariffs.⚈Skepticism remains due to Cramer’s history of controversial stock calls.The former hedge fund manager and host of Mad Money, Jim Cramer, has been overwhelmingly bullish about the U.S. economy and equities in 2025, repeatedly voicing his confidence that America will win the escalating trade war with China.The trend continued on Monday, April 28, afte ...
TJX (TJX) Rises Yet Lags Behind Market: Some Facts Worth Knowing
ZACKS· 2025-04-22 22:50
Company Performance - TJX's stock closed at $125.71, reflecting a +1.4% change from the previous day, underperforming compared to the S&P 500's gain of 2.51% [1] - Over the past month, TJX shares increased by 3.66%, outperforming the Retail-Wholesale sector, which declined by 6.97%, and the S&P 500, which fell by 8.86% [1] Upcoming Earnings - The upcoming EPS for TJX is projected at $0.90, indicating a 3.23% decrease from the same quarter last year [2] - Revenue is expected to reach $12.97 billion, representing a 3.94% increase compared to the corresponding quarter of the previous year [2] Annual Estimates - For the annual period, earnings are anticipated to be $4.43 per share, with revenue projected at $58.75 billion, reflecting increases of +3.99% and +4.24% respectively from the previous year [3] - Changes in analyst projections for TJX are important indicators of business trends, with positive revisions suggesting a favorable outlook [3] Valuation Metrics - TJX has a Forward P/E ratio of 27.98, which is higher than the industry average of 21.15 [5] - The company also has a PEG ratio of 3.08, compared to the Retail - Discount Stores industry's average PEG ratio of 2.64 [6] Industry Context - The Retail - Discount Stores industry is part of the Retail-Wholesale sector, holding a Zacks Industry Rank of 164, placing it in the bottom 34% of over 250 industries [7] - The Zacks Industry Rank indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]
The Zacks Analyst Blog AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment
ZACKS· 2025-04-16 09:35
Group 1: Company Highlights - AbbVie Inc. has outperformed the Zacks Large Cap Pharmaceuticals industry over the past year with a growth of +10.2% compared to the industry's decline of -12.5%. The company's products, Skyrizi and Rinvoq, are performing well due to new approvals, and robust revenue growth is expected in 2025 following the loss of exclusivity for Humira [4][5] - The TJX Companies, Inc. has outperformed the Zacks Retail – Discount Stores industry over the last six months with a growth of +11.2% compared to +2.2% for the industry. The company benefits from a strong focus on customer experience and consistent increases in customer transactions [5][6] - The Charles Schwab Corp. has underperformed the Zacks Financial – Investment Bank industry over the past six months, with a growth of +5.3% compared to +19.8% for the industry. The company is facing increased expenses due to investments in growth areas and subdued trading revenues [6][7] - Enzo Biochem, Inc. has significantly underperformed the Zacks Medical – Biomedical and Genetics industry over the past year, with a decline of -69.6% compared to -12.6% for the industry. The company faces challenges from market demand and pricing pressures, along with sustained net losses [7][8] - CVD Equipment Corp. has outperformed the Zacks Manufacturing – General Industrial industry over the last six months with a decline of -8.9% compared to -15.2% for the industry. Innovations in products position the company for growth in high-demand markets, despite facing challenges from market overcapacity and fluctuating revenues [8][9] Group 2: Market Trends and Challenges - AbbVie faces near-term headwinds including biosimilar erosion of Humira, competitive pressure on Imbruvica, and slow market growth for Juvederm fillers in the U.S. and China [5] - TJX is experiencing concerns over increased store wage and payroll costs, as well as negative impacts from unfavorable currency translations [6] - Charles Schwab's subdued trading revenues raise concerns due to volatile capital market performance, although opportunistic acquisitions have led to a rise in client assets [7] - Enzo Biochem's long-term recovery is challenged by compliance costs and increased competition, which threaten operational resilience amid macroeconomic issues [8] - CVD Equipment faces challenges from silicon carbide market overcapacity and declining liquidity, which pressure margins in the volatile semiconductor sector [9]